BEONE MEDICINES LTD. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
BEONE MEDICINES LTD. (BEIGF) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $19.80 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-26
- BEONE MEDICINES LTD. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $19.80, a 58.02% increase from fiscal 2024.
- BEONE MEDICINES LTD. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $12.53, a 23.46% decline from fiscal 2023.
- BEONE MEDICINES LTD. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $16.37, a 32.66% increase from fiscal 2022.
- BEONE MEDICINES LTD. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $12.34, a 53.36% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $19.80 10-K · filed 2026-02-26 |
| 2024-12-31 | $12.53 10-K · filed 2025-02-27 |
| 2023-12-31 | $16.37 10-K · filed 2025-02-27 |
| 2022-12-31 | $12.34 10-K · filed 2025-02-27 |
| 2021-12-31 | $26.46 10-K · filed 2024-02-26 |
| 2020-12-31 | $13.54 10-K · filed 2023-02-27 |
| 2019-12-31 | $9.38 10-K · filed 2022-02-28 |